Injective USDC Adoption Expands Across Cosmos and dYdX as INJ Price Holds Near $8
Key Takeaways
- •Injective's native USDC is becoming a canonical stablecoin standard across Cosmos and dYdX, with more than $80 million in USDC part of the transition.
- •Cosmos Hub has already moved its treasury to Injective USDC, while dYdX is voting on a governance proposal to migrate approximately $68 million in USDC.
- •Circle's planned discontinuation of Noble USDC services in January 2027 sets a deadline, and the dYdX v9.9 upgrade scheduled for November 17, 2026 is expected to introduce the new USDC routing through Injective.
- •INJ is trading near $8, with support in the $7.70-$7.80 region and resistance around $8.24, while the daily RSI remains in neutral territory.
- •Analyst Crypto Patel maintains long-term INJ targets of $30, $50, and $100, citing the token's roughly 252% gain from his accumulation zone and its relative strength during broader market weakness.

Injective is expanding its role across the Cosmos ecosystem as its native USDC becomes a shared stablecoin standard for cross-chain liquidity and trading. The transition involves more than $80 million in USDC, including Cosmos Hub's treasury and a proposed $68 million migration from dYdX. The development comes as the INJ price shows relative strength despite broader cryptocurrency market weakness, holding near $8, while analyst Crypto Patel maintains long-term targets of $30, $50, and $100.
Injective Positions USDC as a Canonical Standard Across Cosmos and dYdX
Injective is positioning its native USDC as a common stablecoin standard across Cosmos and dYdX. According to the project, more than $80 million in USDC is involved in the transition.
Cosmos Hub has already moved its treasury to Injective USDC. Meanwhile, dYdX is voting on a proposal to migrate approximately $68 million in USDC. The decentralized perpetual trading platform processes more than $1 billion in monthly trading volume, making its participation particularly significant.
Injective USDC is becoming the canonical standard across @cosmos and dYdX, with $80M+ in USDC waiting to migrate. @cosmoshub already moved its treasury to Injective @USDC . Now @dYdX , a perp DEX doing $1B+ a month, is voting to move its $68M share. pic.twitter.com/A9K80by8tL
— Injective 🥷 (@injective) November 14, 2026
The transition is designed to reduce stablecoin fragmentation and establish a common liquidity standard. It also connects Injective's infrastructure with Circle's Cross-Chain Transfer Protocol (CCTP), which supports USDC transfers across compatible blockchain networks.
Cosmos and dYdX Put $80 Million USDC Migration in Focus
The migration could consolidate stablecoin liquidity across several major applications. Cosmos Hub has completed its treasury transition, while dYdX represents a significant portion of the remaining funds.
Timing matters as well: Circle's planned discontinuation of Noble USDC services in January 2027 sets a defined window for networks across the Cosmos ecosystem to complete the move, which adds weight to the migration effort.
Injective's initiative could improve liquidity management and make stablecoin transfers more accessible across supported networks, while also strengthening the network's position in decentralized finance. The dYdX transition is particularly important because of the platform's trading activity. Greater adoption could bring additional stablecoin usage to Injective, although increased USDC circulation does not automatically create equivalent demand for INJ. With dYdX's share still subject to its governance vote, the outcome of that proposal is a near-term item to watch for cross-chain stablecoin flows.
INJ Price Holds $8 Despite Broader Market Weakness
The INJ price has attracted attention because of its relative performance during recent market weakness.
Crypto analyst Crypto Patel stated that the token has gained approximately 252% from his accumulation zone and continues to hold near its recent highs despite selling pressure across the broader cryptocurrency market.
Source: Crypto Patel's X post
This resilience suggests that buyers have continued supporting the INJ price during challenging conditions. Injective's expanding stablecoin infrastructure also provides additional ecosystem context for the token's performance. However, relative strength alone does not confirm a sustained bullish trend, and traders will continue monitoring market demand and network activity.
Crypto Patel Maintains $30, $50, and $100 INJ Targets
INJ is trading near $8, with the $7.70–$7.80 region acting as immediate support. The token's ability to maintain this area could help preserve its short-term recovery structure.
On the upside, resistance sits around $8.24. A sustained breakout above this level could bring $8.62 into focus. However, a move below $7.70 could weaken the current structure and expose the INJ price to further selling pressure.
The daily Relative Strength Index (RSI) is near neutral territory, indicating that momentum has not reached overbought conditions. Traders are therefore watching whether buying pressure can support another upward move.
Crypto Patel maintains three long-term targets for INJ: $30, $50, and $100. His outlook is based on the token's relative strength and performance during broader market weakness, which the analyst considers an important sign for long-term investors.
These targets remain speculative projections rather than confirmed price levels. Reaching them would require sustained demand, favorable market conditions, and continued ecosystem development.
What Comes Next for INJ
The upcoming dYdX v9.9 upgrade is another important development. Scheduled for November 17, 2026, it is expected to introduce the new USDC routing through Injective. Circle's January 2027 discontinuation of Noble USDC services adds urgency to completing the migration on schedule.
For INJ, traders will monitor the $7.70 support and the $8.24 resistance while watching further stablecoin adoption across the ecosystem.
This article contains market analysis and price predictions. These are not guarantees. Crypto markets are volatile. Always DYOR. This is not financial advice.